723 total citations 28 papers, 614 citations indexed
About
Sartorelli Ac is a scholar working on Oncology, Molecular Biology and Cancer Research.
According to data from OpenAlex, Sartorelli Ac has authored 28 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Sartorelli Ac's work include Cancer therapeutics and mechanisms (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Sartorelli Ac is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Sartorelli Ac collaborates with scholars based in United States and Singapore. Sartorelli Ac's co-authors include Christina Gamba‐Vitalo, Sara Rockwell, M Tomasz, Capizzi Rl, Cheol-Su Kim, S. T. Mayne, Chang‐Woo Lee, Hiromitsu Yabushita, Germana Rappa and Aurelio Lorico and has published in prestigious journals such as Blood, Leukemia and PubMed.
In The Last Decade
Sartorelli Ac
28 papers
receiving
552 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Sartorelli Ac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sartorelli Ac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sartorelli Ac more than expected).
This network shows the impact of papers produced by Sartorelli Ac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sartorelli Ac. The network helps show where Sartorelli Ac may publish in the future.
Co-authorship network of co-authors of Sartorelli Ac
This figure shows the co-authorship network connecting the top 25 collaborators of Sartorelli Ac.
A scholar is included among the top collaborators of Sartorelli Ac based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Sartorelli Ac. Sartorelli Ac is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Lorico, Aurelio, et al.. (2001). Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignancies.. PubMed. 6(4). 256–65.18 indexed citations
2.
Ishiguro, Kimiko, et al.. (1998). Role of gp55 in restoring the sensitivity of Friend murine erythroleukemia cells to erythropoietin by exposure to dimethyl sulfoxide.. PubMed. 10(4). 175–84.2 indexed citations
Lee, Chang‐Woo, et al.. (1995). Differentiation of HL-60 cells by dimethylsulfoxide activates a Na(+)-dependent nucleoside transport system.. PubMed. 8(5). 795–801.20 indexed citations
5.
Ac, Sartorelli, et al.. (1994). Mitomycin C: a prototype bioreductive agent.. PubMed. 6(10-11). 501–8.96 indexed citations
6.
Yabushita, Hiromitsu & Sartorelli Ac. (1993). Effects of sodium butyrate, dimethylsulfoxide and dibutyryl cAMP on the poorly differentiated ovarian adenocarcinoma cell line AMOC-2.. PubMed. 5(4-5). 173–82.7 indexed citations
7.
Gamba‐Vitalo, Christina, et al.. (1991). Effects of recombinant murine granulocyte-macrophage colony-stimulating factor in cyclophosphamide-treated mice.. PubMed. 17(1). 193–205; discussion 206.5 indexed citations
8.
Ac, Sartorelli, et al.. (1990). Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines.. PubMed. 2(5). 189–99.6 indexed citations
9.
Rockwell, Sara, et al.. (1989). Modulation of the cytotoxicity of porfiromycin by dicoumarol in vitro and in vivo.. PubMed. 9(4). 817–20.10 indexed citations
Ac, Sartorelli, et al.. (1987). Competent metabolic utilization of hydrogen peroxide by trypanosomes.. PubMed. 44(4). 461–2.4 indexed citations
12.
Ac, Sartorelli, et al.. (1981). The effects of inhibitors of DNA biosynthesis on the cytotoxicity of 6-thioguanine.. PubMed. 5(3). 189–94.34 indexed citations
13.
Ac, Sartorelli, et al.. (1980). Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.. PubMed. 18(3). 507–12.15 indexed citations
14.
Ac, Sartorelli, et al.. (1979). Effects of the bioreductive alkylating agent 2,3-bis(chloromethyl)-1,4-naphthoquinone on coupled mitochondria isolated from sarcoma 180 ascites cells.. PubMed. 3(3). 129–34.5 indexed citations
15.
Wodinsky, I, et al.. (1977). 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.. PubMed. 37(6). 1692–6.14 indexed citations
16.
Rl, Capizzi, et al.. (1977). Combination chemotherapy--theory and practice.. PubMed. 4(2). 227–53.29 indexed citations
17.
Ac, Sartorelli, et al.. (1974). Quinones as anticancer agents: potential bioreductive alkylating agents.. PubMed. 4(4). 23–5.10 indexed citations
18.
Ac, Sartorelli, et al.. (1971). Inhibition of deoxyribonucleotide synthesis by pyridine carboxaldehyde thiosemicarbazones.. PubMed. 31(3). 235–8.39 indexed citations
19.
Ac, Sartorelli, et al.. (1964). DEVELOPMENT, MAINTENANCE AND ASSAY OF DRUG RESISTANCE.. PubMed. 10. 247–62.96 indexed citations
20.
Ac, Sartorelli, et al.. (1957). Purine synthesis in ascites tumor cells.. PubMed. 15(1). 169–80.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.